Literature DB >> 7502588

[Regional adjuvant therapy in colorectal liver metastases: requirements for clinical therapy studies from the statistical viewpoint].

H H Müller1, H Schäfer.   

Abstract

The most important methodical principles of clinical trials in oncology are presented and applied to the special field of adjuvant chemotherapy for liver metastases in colorectal cancer. The presentation is based on accepted biometrical principles in medicine and on our experience in several cancer trials. Special regard is given to the German multicenter study of the liver metastases working group in the "Deutsche Krebsgesellschaft".

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7502588

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN： 0044-409X            Impact factor:   0.942


  3 in total

Review 1.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

2.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

Authors:  M Lorenz; H H Müller; H Schramm; H J Gassel; H G Rau; K Ridwelski; J Hauss; R Stieger; K W Jauch; W O Bechstein; A Encke
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

3.  [The resection of the liver metastases of primary colorectal tumors. The development of a scoring system to determine the individual prognosis based on an assessment of 1568 patients].

Authors:  M Lorenz; M Waldeyer
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 3.621
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.